IFSC
At 2:30 pm Paris time on September 30, 2021, SHENZHEN FUTIAN FASHION INVESTMENT 2021 PARIS FORUM was successfully held in Paris, France with the support of Futian District People’s Government of Shenzhen Municipality, which showed the charm of Futian to the world.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211001005355/en/
The forum is not only a grand event for the development of the fashion industry in Futian District, but also another achievement of the exchanges between China and France in the field of fashion. With Shenzhen Futian Fashion Investment Promotion as the core, this forum will promote Futian's high-quality business environment, industrial foundation and industrial projects to the world. International institutions, fashion brands and international talents are warmly invited to Futian for development.
With the help of the international professional organization, Futian International Fashion Strategy Committee, and rely on the top fashion event of Paris Fashion Week to gather high-end international fashion resources. The event was actively participated by top fashion authority in the world, French government agencies, international luxury groups, and international fashion media. This event was strongly supported by Paris La Défense, GBD Innovation Club, DEFI La Mode de France, Federation de la Haute Couture de la Mode, Kering Group, Institut Français de la Mode, EnaMoMa by PSL, Comité Professionnel de Développement de l'Horlogerie, de la Bijouterie, de la Joaillerie, de l'Orfèvrerie et des Arts de la Table, , , Le Chinese Business Club, Who's Next (WSN) and other French institutions and international organizations. Mr. Pierre-Yves Guice, CEO of Paris La Défense, President of GBD Innovation Club, Mr. Pascal Morand, Executive President of Fédération de la Haute Couture et de la Mode, Head of Global Fashion and Design Department, top fashion authority in the world, Mr. Sébastien Vicente, Head of Art de Vivre Department of Business France, and other international guests attended this event. 150 Paris entrepreneurs, guests in the industry and international media also attended this event, and talked about innovation and development and win-win cooperation with representatives of Shenzhen Futian District, the most active and innovative CBD in China.
Hand in Hand Towards a Bright Future
Mr. Zhou Jiangtao, Acting District Mayor of Futian District People’s Government of Shenzhen Municipality said, Futian is seizing major historical opportunities such as the construction of Guangdong-Hong Kong-Macao Greater Bay Area and Shenzhen Pilot Demonstration Zone, highlighting the ‘three major industries’ of science and technology, finance, and fashion, and striving to build a central innovation zone, a central business district, and a central vitality zone.
Optimize the business environment and cultivate fertile ground for the international development of the fashion industry.
Shenzhen Futian CBD Comprehensive Development Index ranks among the top three in China. In 2020, it became an official member of the GBD Innovation Club.
FuTian–the New Power of International Fashion
Ms. Meng Man, Deputy District Mayor of Futian District People’s Government of Shenzhen Municipality and Vice President of IFSC, gave a keynote speech through a video, stating that "Futian will make every effort to build a cluster of fashion industry development with a core engine + multi-point support." Futian District is looking forward to working with international fashion companies, professional institutions, and talents around the world to" build a plateau of China's fashion industry and jointly open up a new territory for the world's fashion industry".
International Summit Forum brings together celebrities in the international fashion industry
At this event, two major thematic summit forums were held on "Innovative Development of GBD" and "Future Development of International Fashion Industry". A number of international fashion business executives participated in the exchange and discussed the development model of the city's core business districts and fashion industry and international innovation cooperation matters. The guests at the conference fully recognized Futian’s business planning and fashion development concepts, and expressed their willingness to develop in Futian.
Deepen international cooperation and create an "international designer alliance"
Explore a new mode of cooperation in the international fashion field
Futian is one of China's fashion industry centers, with more than 2,000 fashion companies and an industry scale of more than 120 billion yuan. It also has strong advantages in the fashion design industry. Among them, the high-end clothing and architectural decoration design industries are far ahead in China and well-known internationally. After the event, Ms. Dong Shan, Director of Futian District Culture, Radio, Television, Tourism and Sports Bureau of Shenzhen, and Executive Director of IFSC, said in a video interview with the media, Futian District constantly stimulates new momentum for the integration and development of the fashion industry, builds an international professional service industry cluster, and all-round grafting of international fashion resources, realizing the gathering of resources in the international fashion value chain, and building a “world-class bay area fashion center”.
In this event, International Fashion Strategy Committee of Futian District signed the “Letter of Intent on Paris Outstanding Designer Fashion Cooperation Project” with EnaMoMa by PSL, and established a formal international cooperation relationship between Shenzhen Futian and Paris in the field of fashion and design. Together the two parties would build a bridge for cooperation between a large number of outstanding international designers and various fashion brand enterprises, thereby building a healthy ecosystem of the international fashion industry.
As China's first urban and regional international fashion strategy executive agency, Futian International Fashion Strategy Committee has actively carried out international fashion industrialization exchanges and cooperation, attracting international resources to promote the joint work, deeply entering the international stage of the fashion industry, and fully displaying the international city image of Futian, Shenzhen. It is hoped that through series of promotion activities, exchanges between China and France and international influence of China’s fashion forces represented by Futian will be promoted, letting the world set focus on Shenzhen Futian!
View source version on businesswire.com: https://www.businesswire.com/news/home/20211001005355/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Compass Pathways Announces FDA Acceptance of IND Application for PTSD and Hosts Webinar on PTSD and TRD7.1.2026 12:30:00 CET | Press release
FDA Accepts Investigational New Drug (IND) Application for COMP360 for the treatment of post-traumatic stress disorder (PTSD), enabling initiation of late-stage trialCompass continues to advance commercial preparations to be launch-ready by the end of the year for COMP360 for treatment-resistant depression (TRD)Management will host webinar with KOL and industry leaders to discuss PTSD clinical trial and commercial preparations for TRD from 10:00-11:30 am ET on January 7th Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, today announced that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application for COMP360, enabling the initiation of a late-stage clinical trial in patients with PTSD. Compass management, along with KOL and industry leaders, will host a webinar today to discuss the company’s clinical trial plans for PTSD, as well as commercial preparations f
Stallergenes Greer Expands Venom Immunotherapy Production Capacity With Acquisition of Entomon s.r.l.7.1.2026 11:07:00 CET | Press release
Stallergenes Greer, a global leader in allergy therapeutics, today announced that it has entered into an agreement to acquire Entomon s.r.l., an Italian company specialising in the production of certified stinging-insect venom extracts, notably of the Hymenoptera order, used for the manufacture of diagnostic preparations and Venom Immunotherapy (VIT). The transaction is expected to close by the end of January. Entomon, currently recognised as the only company in Europe capable of extracting pure venom from Hymenoptera insects, produces pharmaceutical-grade insect venom using proprietary techniques (Entomon Capillary Extracted Venom®) for medical use. Through this acquisition, Stallergenes Greer bolsters its venom manufacturing capabilities and supply of raw materials for life-saving VIT treatments, whilst safeguarding patient care continuity. Hymenoptera venom allergy is the most common trigger of severe anaphylaxis in adults1. According to the EAACI guidelines on venom immunotherapy,
ARIS Announces New CEO to Lead Agentic AI-led Strategy7.1.2026 10:00:00 CET | Press release
CEO Appointment ARIS, a global leader in process intelligence and transformation software, today announced the appointment of Guillaume Bacuvier as Chief Executive Officer. Guillaume will lead ARIS through its next phase of growth as a fully standalone company, accelerating its evolution from a market leader in Process Intelligence into a foundational platform for enterprises deploying and governing Agentic AI. Guillaume brings deep international leadership experience across technology, data, and software-enabled businesses, with a proven track record of scaling global platforms and leading complex organisations. After starting as a strategic consultant at Booz Allen Hamilton, Guillaume spent over a decade at Google, rising to Vice President in EMEA where he built and scaled some of Google’s largest data-driven businesses in Europe and held P&L responsibility across multiple countries. In the last decade, Guillaume has served as CEO of multi-continent, data-centric companies including
I Squared Capital Acquires Ramudden Global, a Leader in Traffic Management and Infrastructure Safety7.1.2026 09:00:00 CET | Press release
Acquisition will accelerate Ramudden’s ambitious growth plan across North America and Europe supported by strong infrastructure spending tailwinds I Squared Capital, a leading global infrastructure investment manager, today announced that, through its flagship fund, it has agreed to acquire Ramudden Global, from funds advised by Triton Partners (“Triton”), a leading European mid-market sector-specialist investor. Ramudden Global is a leading international provider of traffic management and infrastructure safety services supporting the maintenance and upgrade of essential transport and utility networks. The company operates more than 190 depots across 13 countries in Europe and North America delivering mission-critical services that help to ensure safety, regulatory compliance and continuity of service across road, utility and broader infrastructure works. This investment underscores I Squared Capital’s commitment to investing in essential, regulated, infrastructure businesses that unde
RoslinCT and BOOST Pharma Announce Strategic Manufacturing Agreement to Advance Cell Therapy for Infants with Osteogenesis Imperfecta7.1.2026 09:00:00 CET | Press release
RoslinCT, a global contract development and manufacturing organization (CDMO) specializing in advanced cell therapies, and BOOST Pharma, a clinical-stage biotechnology company developing first-in-class cell therapies for rare paediatric skeletal diseases, today announced a strategic manufacturing partnership to support the development of BOOST Pharma’s cell therapy, BT-101, for the treatment of infants with Osteogenesis Imperfecta (OI), also known as brittle bone disease. Under the service agreement, BOOST Pharma has transferred its manufacturing process to RoslinCT’s state-of-the-art facilities in Edinburgh, Scotland. The partnership will progress toward GMP manufacturing of starting materials and clinical drug product, supporting Phase III clinical development of BT-101. The therapy is an allogeneic mesenchymal stem cell (MSC) product designed to address the underlying cause of OI at the earliest stages of life. BOOST Pharma was founded on pioneering science originating from Karolins
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
